Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
7.73
+0.48 (6.62%)
At close: Jun 22, 2026, 4:00 PM EDT
7.80
+0.07 (0.91%)
After-hours: Jun 22, 2026, 6:22 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $81.52 million as of June 22, 2026. Its market cap has increased by 157.55% in one year.
Market Cap
81.52M
Enterprise Value
24.24M
1-Year Change
157.55%
Ranking
Category
Stock Price
$7.73
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $81.52M, a decrease of -96.75%. That is a compound annual growth rate of -43.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 81.52M | -62.42% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulgent Genetics | 511.21M |
| Myriad Genetics | 428.79M |
| Prenetics Global | 344.98M |
| Insight Molecular Diagnostics | 175.65M |
| Biodesix | 169.93M |
| Exagen | 109.69M |
| Precipio | 40.13M |
| MDxHealth | 27.89M |